Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2002, p. 2262-2265, Vol. 46, No. 7
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.7.2262-2265.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Béatrice Hanau-Berçot,1 Jérome Gravisse,1 Roger Labia,2 Guillaume Arlet,3 and Marie-José Sanson-Le-Pors1
Service de Bacteriologie-Virologie, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, 75475 Paris Cedex 10,1 Centre National de la Recherche Scientifique, Unité FRE 2125, 29000 Quimper,2 Service de Bactériologie, Hôpital Tenon, AP-HP, 75970 Paris Cedex 20, France3
Received 15 October 2001/ Returned for modification 12 January 2002/ Accepted 7 April 2002
Klebsiella pneumoniae KOL, a clinical strain resistant to various ß-lactams, was isolated from the stools of a patient from Greece. This strain harbored a new pI 9.1 plasmid-mediated AmpC ß-lactamase with unusually high levels of hydrolytic activity for cefoxitin and cefotetan that we named MOX-2. Sequencing of blaMOX-2 revealed 93.2, 92.9, 92.7, and 73.1% identities with the deduced amino acid sequences of CMY-8, MOX-1, CMY-1, and the AmpC ß-lactamase of Aeromonas sobria, respectively.
Present address: Laboratoire de la Polyclinique d'Aubervilliers, Hôpital Européen de Paris, 93300 Aubervilliers, France.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»